Skip to main content
BBOT logo

BBOT

BridgeBio Oncology Therapeutics, Inc.
$8.32 -0.77 (-8.47%) At close · Jul 10
Market Cap
$666.49M
Shares
80,107,104

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 67
Total Value: $514,044,897
Total Shares: 57,435,188

Institutional Ownership Trend

3 quarters

Holder Concentration

Across 67 13F filers · Δ vs Dec 31, 2025
Top Holder
31.1%
Sep 2025 → Mar 2026 · range 30.7% – 31.5%
+0.5 pts
Top 5
55.2%
Sep 2025 → Mar 2026 · range 54.5% – 56.0%
+0.7 pts
Top 10
76.5%
Sep 2025 → Mar 2026 · range 75.7% – 77.2%
+0.9 pts
HHI
1,246
Sep 2025 → Mar 2026 · range 1,222 – 1,278
Broadly held+24

Quarterly Activity

vs Dec 31, 2025
New
23
Increased
20
Decreased
11
Sold Out
9
Unchanged
13
Holder count: +14
Institutional value: -29.6%
Shares held: -1.5%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 67 of 67
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1869105 CUSIP 107924102 13F (30d) 1 filings 1 filers Visit website Investor relations